Τόμος 22 (2008) – Τεύχος 2 – Άρθρο 33 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 22 (2008) – Issue 2 – Article 33 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Hyaluronic acid induces wound closure by primary human skin fibroblasts in a wound healing model
Authors D. Economou¹, E. Papakonstantinou², I. Klagas², Ath. Sakadamis³ and A. Sioga¹

1. Department of Histology-Embryology and 2. Department of Pharmacology, 3. 2nd Department of Surgery, School of Medicine, Aristotle University of Thessaloniki, Greece

Citation Economou, D., Papakonstantinou, E., Klagas, I., Sakadamis, A., Sioga, A.: Hyaluronic acid induces wound closure by primary human skin fibroblasts in a wound healing model, Epitheorese Klin. Farmakol. Farmakokinet. 22(2): 138-140 (2008)
Publication Date 23-25 May 2008
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)

pharmakonpress[at]pharmakonpress[.]gr

Keywords Glycosaminoglycans, matrix metalloproteinase-2, primary human skin fibroblasts, migration, wound healing.
Other Terms Review article
Summary Hyaluronic acid (HA) is the most common glycosaminoglycan present in the extracellular matrix of epidermis and dermis. In the present study, we investigated the effect of HA on the migration of primary human skin fibroblasts in a wound healing model. 5e found that HA (1 μg/ml) enhances in a time-dependent manner (2-48 h) the migration of human skin fibroblasts. This effect was associated with an increased secretion of MMP-2 gelatinolytic activity and an induction in MMP-2 gene expression, as assessed by gelatin zymography and RT-PCR, respectively. Our results indicate that HA regulates the migration of human skin fibroblasts by stimulation of MMP-2 and may offer an additional target for pharmacological intervention in wound healing.
References 1.         Papakonstantinou E., Karakiulakis G., Eickelberg O., et al.: A 340 kDa hyaluronic acid secreted by human vascular smooth muscle cells regulates their proliferation and migration. Glycobiology 8: 821-830 (1998)

2.        Ruoslahti E., Yamaguchi Y.:  Proteoglycans as

modulators of growth factor activities. Cell 64: 867-869 (1991)

3.        Stocker W., Grams F., Baumann U., et al.: The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci. 4: 823-840 (1995)

4.        Kerkela E., Saarialho-Kere U.: Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp. Dermatol. 12: 109-125 (2003)

5.        Nova D., Le Griel C., Holvoet S., et al. Comparative studies on the secretion and activation of MMPs in two reconstructed human skin models using HaCaT- and HaCaT-ras-transfected cell lines. Clin. Exp. Metastasis 20: 675-683 (2003)

6.        Singer A.J., Clark R.A.F.: Cutaneous wound healing. N. Engl. J. Med. 341: 738-746 (1999)

7.         Karakiulakis G., Papanikolaou C., Jankovic S.M., et al.: Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon. Invasion Metastasis 17: 158-168 (1997)

8.        Karakiulakis G., Papakonstantinou E., Aletras A.J., Tamm M., Roth M.: Cell type-specific effect of hypoxia and platelet-derived growth factor-BB on extracellular matrix turnover and its consequences for lung remodeling. J. Biol. Chem.: (2007)

9.        Gotte M., Kresse H.: Defective glycosaminoglycan substitution of decorin in a patient with progeroid syndrome is a direct consequence of two point mutations in the galactosyltransferase I (beta4GalT-7) gene. Biochem. Genet. 43: 65-77 (2005)

10.      Clark R.A., Lin F., Greiling D., An J., Couchman J.R.: Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate- CD44 proteoglycan. J. Invest Dermatol. 122: 266-277 (2004)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2008 – ANNUAL SUBSCRIPTION 2008
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

Bookmark the permalink.

Comments are closed.